Antibacterial activity of ciprofloxacin and trimethoprim, alone and in combination, against Vibrio cholerae O1 biotype El Tor serotype Ogawa isolates

Polish Journal of Microbiology

Volumn 58, Issue 1, 2009, Pages 57-60

  Mandal, Shyamapada ^a,c   Pal, Nishith K ^a   Chowdhury, Imran H ^a   Debmandal, Manisha ^b  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c GURUDAS COLLEGE   (India)

Author keywords

Antibacterial activity; Ciprofloxacin; Fractional inhibitory concentration index; Trimethoprim

Indexed keywords

CIPROFLOXACIN; TRIMETHOPRIM;

AGAR DILUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOTYPE; CASE REPORT; CHOLERA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE; VIBRIO CHOLERAE;

ANTI-INFECTIVE AGENTS, URINARY; CHOLERA; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; TRIMETHOPRIM; VIBRIO CHOLERAE O1;

VIBRIO CHOLERAE;

EID: 66649108179     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bertolini, A., M. Castelli, S. Genedani and M. Garuti. 1980. Trimethoprim enhances the antimicrobial activity of nalidixic acid and oxolinic acid and delays the emergence of resistance. Experimentia. 36: 243-244. (Pubitemid 10101379)
2. Bhattacharya M. K., D. Dutta, T. Ramamurthy, D. Sarkar, A. Singharoy and S. K. Bhattacharya. 2003. Azithromycin in the treatment of cholera in children. Acta. Pediatr. 92: 676-678. (Pubitemid 37088674)
3. Craig W. A. and B. Vogelman. 1987. The Post antibiotic effect. Annals Internal Med. 106: 900-902.
4. Das S. and S. Gupta. 2005. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000. J. Health Popul. Nutr. 23: 44-51. (Pubitemid 40668001)
5. Garg P., S. Chakraborty, I. Basu, S. Datta, K. Rajendran, T. Bhattacharya, S. Yamasaki, S. K. Bhattacharya, Y. Takeda, G. B. Nair and T. Ramamurthy. 2000. Expanding multiple antibiotic among clinical strains of Vibrio cholerae isolated from 1992-7 in resistance Calcutta, India. Epidemiol. Infect. 124: 393-399. (Pubitemid 30623855)
6. Garg P., S. Sinha, R. Chakraborty, S.K. Bhattacharya, G.B. Nair and T. Ramamurthy. 2001. Emergence of fluroquinolone resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrob. Agents Chemother. 45: 1605-1606. (Pubitemid 32374149)
7. Genedani S., M. Castelli, P. Foresta and A. Bertolini. 1983. Oxolinic acid-trimethoprim combination: Effects on DNA synthesis and on viability of Escherichia coli. Chemotherapy. 29: 24-27. (Pubitemid 13179742)
8. Huovinen P., J.S. Wolfson and D.C. Hooper. 1992. Synergism of trimethoprim and ciprofloxacin against clinical bacterial isolates. Eur. J. Clin. Microbiol. Infect. Dis. 11: 255-257.
9. Krogstad D.J. and R.C. Moellering. 1980. Combinations of antibiotics, mechanisms of interaction against bacteria, pp. 298-341. In: Lorian V. (ed). Antibiotics in Laboratory Medicine. The Williams and Wilkins Co., Baltimore.
10. Leclercq R., E. Bingen, Q.H. Su, N. Lambert-Zechovski, P. Courvalin and Duval. 1991. Effects of combinations of β-lactams, daptomycin, gentamycin and glycopeptides against glycopeptide resistant Enterococci. Antimicrob. Agents Chemther. 35: 92-98.
11. Mandal S., M.D. Mandal and N.K. Pal. 2003a. Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar Typhi with reduced susceptibility to ciprofloxacin. Jpn. J. Infect. Dis. 56: 156-157. (Pubitemid 37456066)
12. Mandal S., M.D. Mandal and N.K. Pal. 2003b. In vitro efficacy of ciprofloxacin alone and in combination with amoxycillin against Salmonella typhi isolates. Indian J. Exp. Biol. 41: 360-362. (Pubitemid 36405521)
13. Mandal S., M.D. Mandal and N.K. Pal. 2004a. Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar Typhi isolates showing reduced susceptibility to ciprofloxacin. Chemotherapy. 50: 152-154. (Pubitemid 38980439)
14. Mandal S., M.D. Mandal and N.K. Pal. 2004b. Evaluation of combination effect of ciprofloxacin and cefazolin against Salmonella enterica serovar Typhi isolates by in vitro methods. Calicut Med. J. 2, e2. URL: http://www. calicutmedicaljournal.org/2004/2/2/e2
15. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; Approved Standards. 1997. NCCLS, Wayne, Pa. USA.
16. Saha D., W.A. Khan, M.M. Karim, H.R. Chowdhury, M.A. Salam and M. L. Bennish. 2005. Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. Lancet. 366: 1054-1055. (Pubitemid 41338762)
17. Samal B., S.K. Ghosh, S.K. Mohanty and K. Patnaik. 2001. Epidemic of Vibrio cholerae serogroup O139 in Berhampur, Orissa. Indian J. Med. Res. 114: 10-11. (Pubitemid 33103901)
18. Sengupta P.G., S.K. Niyogi and S.K. Bhattacharya. 2000. An outbreak of El Tor cholera in Aizwal town of Mizoram. Indian J. Commun. Dis. 32: 207-211.
19. Taneja N., M. Biswal, B. Tarai and M. Sharma. 2005. Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India. Jpn. J. Infect. Dis. 58: 238-240. (Pubitemid 41460931)
20. Vogelman B. and W.A. Craig. 1986. Kinetics of antimicrobial activity. J. Paediatrics. 108: 835-840. (Pubitemid 16063283)
21. Westh H., N. Fimodt, E. Crutschick and J. Bangsborg. 1992. Killing curve activity of ciprofloxacin is comparable to synergistic effect of b-lactam tombramycin combination against Haemophilus species endocarditis strains. APMIS. 100: 856-860.